(including tissue-invasive CMV disease) in 616 ganciclovir; prophylaxis; renal transplantation; recipients of cadaveric renal allografts [2]. Two hun-valacyclovir dred and eight patients were assigned to the CMV high-risk group (CMV positive donor and a CMV negative receptor); this group was called the sero-negative group. Valacyclovir in a dose of 2 g q.i.d. Introduction (adjusted for renal fu...

this study was conducted to evaluate the effects of administering oral acyclovir in conjunction with topical acyclovir and steroids in the treatment of necrotizing herpetic keratouveitis. all patients with necrotizing herpetic keratouveits who have been consulted during 1996-1997 at the farbi eye hospital were studied . the patients were randomly assigned to two groups. in the first group, topi...

The main risk factors for cytomegalovirus (CMV) disease in recipients of allogeneic stem cell transplants (SCT) are recipient CMV seropositivity and acute graft-versus-host disease. Currently, two antiviral strategies, prophylactic or preemptive antiviral treatment, are used for prevention of CMV disease. Preemptive treatment is most favorable when short-term (14-day) treatment is applied. Seve...

purpose: a 12 year-old boy and a known case of job’s syndrome presented with a large conjunctival mass which represented coexistence of hpv and hsv infections. case report: the presence of hpv virus within these lesions was confirmed by biopsy and dna analysis. the mass lesions did not respond to anti-hpv therapy with topical interferon-α2b, oral cimetidine and oral acyclovir, but improved prom...

OBJECTIVE To determine the association of delayed acyclovir therapy with death among neonates with herpes simplex virus (HSV) infection. METHODS A multicenter, retrospective, cohort study was conducted between January 1, 2003, and December 31, 2009, with 1086 neonates (age: ≤28 days) with HSV infection from 41 tertiary care children's hospitals. Early acyclovir therapy was defined as initiati...